Alan Carr analyst NEEDHAM

Currently out of the existing stock ratings of Alan Carr, 56 are a BUY (94.92%), 2 are a SELL (3.39%), 1 are a HOLD (1.69%).

Alan Carr

Work Performance Price Targets & Ratings Chart

Analyst Alan Carr works at NEEDHAM with a stock forecast success ratio of 60.69% fulfilled within 221.76 days on average.

Alan Carr’s has documented 135 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CRSP, Crispr Therapeutics AG at 13-May-2022.

Wall Street Analyst Alan Carr

Analyst best performing recommendations are on BHVN (BIOHAVEN PHARMACEUTICAL HOLDING CO LTD).
The best stock recommendation documented was for CARA (CARA THERAPEUTIC) at 2/27/2014. The price target of $22 was fulfilled within 6 days with a profit of $4.64 (26.73%) receiving and performance score of 44.55.

Average potential price target upside

CRSP Crispr Therapeutics AG GILD Gilead Sciences MRNA Moderna PHAT Phathom Pharmaceuticals VRTX Vertex Pharmaceuticals ACAD ACADIA Pharmaceuticals ALNY Alnylam Pharmaceuticals BHVN Biohaven Pharmaceutical Holding Co Ltd CARA Cara Therapeutic ICPT Intercept Pharmaceuticals LXRX Lexicon Pharmaceuticals TRVN Trevena TTPH Tetraphase Pharmaceuticals VIR Vir Biotechnology NBIX Neurocrine Biosciences RYTM Rhythm Pharmaceuticals VVUS VIVUS ZEAL Zealand Pharma A/S ADR

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

48

$-39.68 (-45.26%)

42

3 days ago

3/6 (50%)

$-38.06 (-44.22%)

143

Hold

80

$-7.68 (-8.76%)

61

7 days ago

9/13 (69.23%)

$-6.19 (-7.18%)

167

Buy

112

$24.32 (27.74%)

110

7 days ago

2/10 (20%)

$25.81 (29.95%)

22

Hold

66

$-21.68 (-24.73%)

57

7 days ago

4/8 (50%)

$-20.19 (-23.42%)

283

Buy

90

$2.32 (2.65%)

88

8 days ago

7/10 (70%)

$7.59 (9.21%)

194

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Alan Carr?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?